DarioHealth Corp. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
DarioHealth Corp. (DRIO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $8.83 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-03-19
- DarioHealth Corp. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2025 was $8.83, a 41.56% decline from fiscal 2024.
- DarioHealth Corp. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $15.11, a 606.07% increase from fiscal 2023.
- DarioHealth Corp. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $2.14, a 51.69% decline from fiscal 2022.
- DarioHealth Corp. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $4.43, a 67.40% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month as first filed |
|---|---|---|
| 2025-12-31 | $8.83 10-K · filed 2026-03-19 | |
| 2024-12-31 | $15.11 10-K · filed 2026-03-19 | $0.76 10-K · filed 2025-03-10 |
| 2023-12-31 | $2.14 10-K · filed 2025-03-10 | |
| 2022-12-31 | $4.43 10-K · filed 2024-03-28 | |
| 2021-12-31 | $13.59 10-K · filed 2023-03-09 | |
| 2020-12-31 | $5.19 10-K · filed 2022-03-22 | |
| 2019-12-31 | $9.41 10-K · filed 2021-03-09 | |
| 2018-12-31 | $11.20 10-K · filed 2020-03-17 | $0.56 10-K · filed 2019-03-25 |
| 2017-12-31 | $2.07 10-K · filed 2019-03-25 | |
| 2016-12-31 | $2.86 10-K · filed 2018-03-19 | |
| 2015-12-31 | $5.94 10-K · filed 2017-03-22 | $0.33 10-K · filed 2016-02-08 |
| 2014-12-31 | $2.82 10-K · filed 2016-02-08 | |
| 2013-12-31 | $7.20 10-K · filed 2015-03-24 | $1.44 10-K · filed 2014-03-04 |
| 2012-12-31 | $0.52 10-K · filed 2014-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |